Priya Singhal - Apr 2, 2024 Form 4 Insider Report for BIOGEN INC. (BIIB)

Role
Head of Development
Signature
/s/ Samuel Ntonme, attorney-in-fact for Priya Singhal
Stock symbol
BIIB
Transactions as of
Apr 2, 2024
Transactions value $
-$19,817
Form type
4
Date filed
4/3/2024, 08:24 PM
Previous filing
Feb 26, 2024
Next filing
Sep 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIIB Common Stock Sale -$19.8K -93 -1.87% $213.09 4.89K Apr 2, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 1. Includes 93.3846 shares acquired under the Biogen Inc. employee stock purchase plan on 3/28/2024.